NDC 49288-0201

Flaxseed

Flaxseed

Flaxseed is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Antigen Laboratories, Inc.. The primary component is Flax Seed.

Product ID49288-0201_afc65820-1d95-4bc6-81a6-ef5ca82cbd81
NDC49288-0201
Product TypeHuman Prescription Drug
Proprietary NameFlaxseed
Generic NameFlaxseed
Dosage FormInjection, Solution
Route of AdministrationINTRADERMAL; SUBCUTANEOUS
Marketing Start Date1974-03-23
Marketing CategoryBLA / BLA
Application NumberBLA102223
Labeler NameAntigen Laboratories, Inc.
Substance NameFLAX SEED
Active Ingredient Strength0 g/mL
Pharm ClassesNon-Standardized Food Allergenic Extract [EPC],Non-Standardized Plant Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Allergens [CS],Dietary Proteins [CS],Plant Proteins [CS],Seed Storage Proteins [CS]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 49288-0201-4

30 mL in 1 VIAL, MULTI-DOSE (49288-0201-4)
Marketing Start Date1974-03-23
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 49288-0201-4 [49288020104]

Flaxseed INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102223
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1974-03-23
Inactivation Date2019-10-21

NDC 49288-0201-2 [49288020102]

Flaxseed INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102223
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1974-03-23
Inactivation Date2019-10-21

NDC 49288-0201-5 [49288020105]

Flaxseed INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102223
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1974-03-23
Inactivation Date2019-10-21

NDC 49288-0201-3 [49288020103]

Flaxseed INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102223
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1974-03-23
Inactivation Date2019-10-21

NDC 49288-0201-1 [49288020101]

Flaxseed INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102223
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1974-03-23
Inactivation Date2019-10-21

Drug Details

Active Ingredients

IngredientStrength
FLAX SEED.05 g/mL

OpenFDA Data

SPL SET ID:040dacaf-4ccf-425a-9b40-586176b7631d
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 891505
  • 978958
  • 966958
  • Pharmacological Class

    • Non-Standardized Food Allergenic Extract [EPC]
    • Non-Standardized Plant Allergenic Extract [EPC]
    • Increased Histamine Release [PE]
    • Cell-mediated Immunity [PE]
    • Increased IgG Production [PE]
    • Allergens [CS]
    • Dietary Proteins [CS]
    • Plant Proteins [CS]
    • Seed Storage Proteins [CS]

    NDC Crossover Matching brand name "Flaxseed" or generic name "Flaxseed"

    NDCBrand NameGeneric Name
    22840-1521FlaxseedLinum usitatissimum
    22840-1523FlaxseedLinum usitatissimum
    22840-5510FlaxseedLinum usitatissimum
    36987-2214FlaxseedFlaxseed
    36987-2215FlaxseedFlaxseed
    36987-2216FlaxseedFlaxseed
    36987-2217FlaxseedFlaxseed
    36987-2218FlaxseedFlaxseed
    36987-2219FlaxseedFlaxseed
    36987-2220FlaxseedFlaxseed
    36987-2221FlaxseedFlaxseed
    49288-0201FlaxseedFlaxseed
    49643-010FlaxseedFlaxseed

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.